210 related articles for article (PubMed ID: 11012474)
1. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
[TBL] [Abstract][Full Text] [Related]
2. Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis.
Clemente C; Elba S; Buongiorno G; Berloco P; Guerra V; Di Leo A
Cancer Lett; 2002 Apr; 178(2):123-9. PubMed ID: 11867196
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the relative dose-response test as indicators of hepatic vitamin A stores in various stages of chronic liver disease.
Arantes Ferreira Peres W; Villaça Chaves G; Saraiva Gonçalves JC; Ramalho A; Moraes Coelho HS
Nutr Clin Pract; 2013 Feb; 28(1):95-100. PubMed ID: 23032273
[TBL] [Abstract][Full Text] [Related]
5. Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation.
Abbott-Johnson W; Kerlin P; Clague A; Johnson H; Cuneo R
J Gastroenterol Hepatol; 2011 Sep; 26(9):1402-10. PubMed ID: 21501225
[TBL] [Abstract][Full Text] [Related]
6. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
[TBL] [Abstract][Full Text] [Related]
7. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
11. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
Ali MA; Koura BA; el-Mashad N; Zaghloul MH
Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
[TBL] [Abstract][Full Text] [Related]
13. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
14. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
16. Serum neopterin levels in patients with hepatocellular carcinoma.
Antoniello S; Auletta M; Magri P; Russo N
Biol Chem Hoppe Seyler; 1992 Nov; 373(11):1165-8. PubMed ID: 1282321
[TBL] [Abstract][Full Text] [Related]
17. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
18. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
Spadaro A; Ajello A; Morace C; Zirilli A; D'arrigo G; Luigiano C; Martino F; Bene A; Migliorato D; Turiano S; Ferraù O; Freni MA
World J Gastroenterol; 2005 Apr; 11(13):1987-90. PubMed ID: 15800991
[TBL] [Abstract][Full Text] [Related]
19. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
20. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]